Premier Psych Llc - Medicare Mental Health Clinic in The Villages, FL

Premier Psych Llc is a medicare enrolled mental health clinic (Psychiatry & Neurology - Psychiatry) in The Villages, Florida. The current practice location for Premier Psych Llc is 1580 Santa Barbara Blvd, The Villages, Florida. For appointments, you can reach them via phone at (352) 259-2159. The mailing address for Premier Psych Llc is 1580 Santa Barbara Blvd, The Villages, Florida and phone number is (352) 259-2159.

Premier Psych Llc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1083246441. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (352) 259-2159.

Contact Information

Premier Psych Llc
1580 Santa Barbara Blvd
The Villages
FL 32159-6827
(352) 259-2159
Not Available

Mental Health Clinic Profile

Full NamePremier Psych Llc
SpecialityPsychiatry & Neurology
Location1580 Santa Barbara Blvd, The Villages, Florida
Authorized Official Name and PositionCynthia Romska (AUTHORIZED OFFICIAL)
Authorized Official Contact3523534212
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Premier Psych Llc
1580 Santa Barbara Blvd
The Villages
FL 32159-6827

Ph: (352) 259-2159
Premier Psych Llc
1580 Santa Barbara Blvd
The Villages
FL 32159-6827

Ph: (352) 259-2159

NPI Details:

NPI Number1083246441
Provider Enumeration Date02/04/2020
Last Update Date02/10/2020
Certification Date02/10/2020

Medicare PECOS Information:

Medicare PECOS PAC ID6204263296
Medicare Enrollment IDO20200304001696

News Archive

Discovery of gene that controls sugar production, implications for diabetes

Scientists in Sydney and Boston believe they may have identified a gene that controls abnormal production of sugar in the liver, a very troublesome problem for people with diabetes.

Study: Black and white men with prostate cancer prioritize treatment-related factors differently

When it comes to making decisions about which prostate cancer treatment to choose, black and white men prioritize certain treatment-related factors differently, according to a University of North Carolina Lineberger Comprehensive Cancer Center study.

New potential drug target for atherosclerosis

A nuclear receptor protein, known for controlling the ability of cells to burn fat, also exerts powerful anti-inflammatory effects in arteries, suppressing atherosclerosis in mice prone to developing the harmful plaques, according to new research by scientists at the Salk Institute for Biological Studies and the Harvard School of Public Health.

Lobbyists play ball, flex muscles on health care reform

The Associated Press reports on lobbying around biotechnology legislation. A letter urging the protection of biotech drug makers from generics from "the private National Health Council, sent to House leaders drafting health overhaul legislation, said the plea was on behalf of 'the more than 133 million Americans living with chronic diseases and disabilities and their family caregivers.'

Ampio announces results from Optina trial on DME

Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing innovative proprietary drugs for inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual dysfunction and conducting clinical trials on its three lead drugs (Ampion, Optina & Zertane), announced the significant results from their further analysis of its Optina trial on DME.

Read more Medical News

› Verified 9 days ago

Medical Identifiers

Medical identifiers for Premier Psych Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1083246441NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084P0800XPsychiatry & Neurology - Psychiatry (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Premier Psych Llc acts as a billing entity for following providers:
Provider NameKenneth Ethan Lai
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1376893974
PECOS PAC ID: 8325266489
Enrollment ID: I20151201001118

News Archive

Discovery of gene that controls sugar production, implications for diabetes

Scientists in Sydney and Boston believe they may have identified a gene that controls abnormal production of sugar in the liver, a very troublesome problem for people with diabetes.

Study: Black and white men with prostate cancer prioritize treatment-related factors differently

When it comes to making decisions about which prostate cancer treatment to choose, black and white men prioritize certain treatment-related factors differently, according to a University of North Carolina Lineberger Comprehensive Cancer Center study.

New potential drug target for atherosclerosis

A nuclear receptor protein, known for controlling the ability of cells to burn fat, also exerts powerful anti-inflammatory effects in arteries, suppressing atherosclerosis in mice prone to developing the harmful plaques, according to new research by scientists at the Salk Institute for Biological Studies and the Harvard School of Public Health.

Lobbyists play ball, flex muscles on health care reform

The Associated Press reports on lobbying around biotechnology legislation. A letter urging the protection of biotech drug makers from generics from "the private National Health Council, sent to House leaders drafting health overhaul legislation, said the plea was on behalf of 'the more than 133 million Americans living with chronic diseases and disabilities and their family caregivers.'

Ampio announces results from Optina trial on DME

Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing innovative proprietary drugs for inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual dysfunction and conducting clinical trials on its three lead drugs (Ampion, Optina & Zertane), announced the significant results from their further analysis of its Optina trial on DME.

Read more Medical News

› Verified 9 days ago

Provider NameJohn Samaan
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1225325988
PECOS PAC ID: 9133413164
Enrollment ID: I20231220003576

News Archive

Discovery of gene that controls sugar production, implications for diabetes

Scientists in Sydney and Boston believe they may have identified a gene that controls abnormal production of sugar in the liver, a very troublesome problem for people with diabetes.

Study: Black and white men with prostate cancer prioritize treatment-related factors differently

When it comes to making decisions about which prostate cancer treatment to choose, black and white men prioritize certain treatment-related factors differently, according to a University of North Carolina Lineberger Comprehensive Cancer Center study.

New potential drug target for atherosclerosis

A nuclear receptor protein, known for controlling the ability of cells to burn fat, also exerts powerful anti-inflammatory effects in arteries, suppressing atherosclerosis in mice prone to developing the harmful plaques, according to new research by scientists at the Salk Institute for Biological Studies and the Harvard School of Public Health.

Lobbyists play ball, flex muscles on health care reform

The Associated Press reports on lobbying around biotechnology legislation. A letter urging the protection of biotech drug makers from generics from "the private National Health Council, sent to House leaders drafting health overhaul legislation, said the plea was on behalf of 'the more than 133 million Americans living with chronic diseases and disabilities and their family caregivers.'

Ampio announces results from Optina trial on DME

Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing innovative proprietary drugs for inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual dysfunction and conducting clinical trials on its three lead drugs (Ampion, Optina & Zertane), announced the significant results from their further analysis of its Optina trial on DME.

Read more Medical News

› Verified 9 days ago

News Archive

Discovery of gene that controls sugar production, implications for diabetes

Scientists in Sydney and Boston believe they may have identified a gene that controls abnormal production of sugar in the liver, a very troublesome problem for people with diabetes.

Study: Black and white men with prostate cancer prioritize treatment-related factors differently

When it comes to making decisions about which prostate cancer treatment to choose, black and white men prioritize certain treatment-related factors differently, according to a University of North Carolina Lineberger Comprehensive Cancer Center study.

New potential drug target for atherosclerosis

A nuclear receptor protein, known for controlling the ability of cells to burn fat, also exerts powerful anti-inflammatory effects in arteries, suppressing atherosclerosis in mice prone to developing the harmful plaques, according to new research by scientists at the Salk Institute for Biological Studies and the Harvard School of Public Health.

Lobbyists play ball, flex muscles on health care reform

The Associated Press reports on lobbying around biotechnology legislation. A letter urging the protection of biotech drug makers from generics from "the private National Health Council, sent to House leaders drafting health overhaul legislation, said the plea was on behalf of 'the more than 133 million Americans living with chronic diseases and disabilities and their family caregivers.'

Ampio announces results from Optina trial on DME

Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing innovative proprietary drugs for inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual dysfunction and conducting clinical trials on its three lead drugs (Ampion, Optina & Zertane), announced the significant results from their further analysis of its Optina trial on DME.

Read more News

› Verified 9 days ago

Psychiatry & Neurology in The Villages, FL

Actions 4 Life
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 2685 Formosa Ter, The Villages, FL 32162
Phone: 941-782-7195    Fax: 877-307-6399
Stroke And Brain Specialists Pa
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1950 Laurel Manor Dr, Bldg 200 Ste 206, The Villages, FL 32162
Phone: 352-414-5322    
Systems Family Therapy Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1985 Odessa Cir, The Villages, FL 32162
Phone: 407-900-9319    
Melinda Nemiroff Psychotherapy Llc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 5837 Wood Stork Way, The Villages, FL 32163
Phone: 561-693-8705    Fax: 561-771-9820
Carol G Fortune Lcsw Pa
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 1522 Golden Ridge Dr, The Villages, FL 32162
Phone: 352-638-2264    Fax: 352-350-7244
Soft Spot Services
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 692 Twinkle Cir, The Villages, FL 32163
Phone: 305-414-1190    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.